An official website of the United States government
NIH Guide: Weekly Index for September 9, 2022
Weekly NIH Guide Notices
September 9, 2022
General Notices
-
Notice of NCCIH Technical Assistance Webinar for RFA-AT-23-001 and RFA-AT-23-002
(NOT-AT-22-031)National Center for Complementary and Integrative Health
-
Notice of Increase to NIGMS K99 Support Levels
(NOT-GM-22-045)National Institute of General Medical Sciences
-
Notice of Pre-Application Webinar for the Maternal Health Research Centers of Excellence Funding Opportunity Announcements
(NOT-HD-22-044)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
RESCINDED - Notice of NIH Participation in the NIH-NSF Ecology and Evolution of Infectious Diseases Program
(NOT-TW-22-005)John E. Fogarty International CenterNational Institute of Allergy and Infectious DiseasesNational Institute of General Medical Sciences
-
Request for Information (RFI): Seeking Input for the National Cancer Institute (NCI) on Expanding the Development of the Integrated Canine Data Commons
(NOT-CA-22-125)National Cancer Institute
-
Request for Information: Future Research Needs and Infrastructure Support for Newborn Screening Research
(NOT-HD-22-042)Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of Changes to Funding Opportunities
-
Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-051, "HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)"
(NOT-AG-22-033)National Institute on Aging
-
Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-053, "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 - Clinical Trial Optional)"
(NOT-AG-22-034)National Institute on Aging
-
Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-054, "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 - Clinical Trial Optional)"
(NOT-AG-22-035)National Institute on Aging
-
Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-049, "HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional)"
(NOT-AG-22-036)National Institute on Aging
-
Notice of NCCIH Participation in PAR-22-181, "NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
(NOT-AT-22-030)National Center for Complementary and Integrative Health
-
Notice of Change to Award Information for RFA-DK-22-506 and RFA-DK-22-507, Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed)
(NOT-DK-22-029)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Additional Receipt Date for RFA-ES-19-011 "Mechanism for Time-Sensitive Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)"
(NOT-ES-22-013)National Institute of Environmental Health Sciences
-
Notice of NEI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)"
(NOT-EY-22-015)National Eye Institute
-
Notice of Early Termination of NOT-OD-22-031, Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
(NOT-OD-22-209)Office of Research on Women's Health
Notices of Special Interest
-
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)
(NOT-OD-22-202)Office of Dietary SupplementsNational Cancer InstituteNational Institute of Diabetes and Digestive and Kidney DiseasesNational Center for Complementary and Integrative Health
-
Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions
(NOT-OD-22-203)Office of Behavioral and Social Sciences ResearchNational Institute on AgingNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Nursing ResearchNational Center for Complementary and Integrative Health
-
Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
(NOT-OD-22-208)Office of Research on Women's HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and Bioengineering
Funding Opportunities
-
Development of Animal Models and Related Materials for HIV/AIDS Research (R24 Clinical Trials Not Allowed)
(PAR-22-204)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): Multiple dates, see announcement.
-
NINR Areas of Emphasis for Research to Optimize Health and Advance Health for All (R01 Clinical Trial Optional)
(PAR-22-230)National Institute of Nursing ResearchApplication Receipt Date(s): Multiple dates, see announcement.
-
NINR Areas of Emphasis for Research to Optimize Health and Advance Health for All (R21 Clinical Trial Optional)
(PAR-22-231)National Institute of Nursing ResearchApplication Receipt Date(s): Multiple dates, see announcement.
-
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
(PAR-22-242)National Cancer InstituteNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Eye InstituteNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): May 23, 2025
-
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
(PAR-22-243)National Cancer InstituteNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): May 23, 2025
-
NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 - Clinical Trial Not Allowed)
(RFA-DA-23-037)National Institute on Drug AbuseNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): November 29, 2022
-
Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier (UC2 Clinical Trial Not Allowed)
(RFA-HD-23-003)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute on Drug AbuseOffice of Dietary SupplementsApplication Receipt Date(s): November 30, 2022
-
Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed)
(RFA-HD-23-023)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): December 06, 2022
-
Multi-Omics for Health and Disease - Disease Study Sites (U01 Clinical Trial Optional)
(RFA-HG-22-008)National Human Genome Research InstituteNational Cancer InstituteNational Institute of Environmental Health SciencesApplication Receipt Date(s): November 18, 2022
-
Multi-Omics for Health and Disease - 'Omics Production Centers (U01 Clinical Trial Not Allowed)
(RFA-HG-22-009)National Human Genome Research InstituteNational Cancer InstituteNational Institute of Environmental Health SciencesApplication Receipt Date(s): November 18, 2022
-
Multi-Omics for Health and Disease - Data Analysis and Coordination Center (U01 Clinical Trial Not Allowed)
(RFA-HG-22-010)National Human Genome Research InstituteNational Cancer InstituteNational Institute of Environmental Health SciencesApplication Receipt Date(s): November 18, 2022
-
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed)
(RFA-OD-22-013)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): Multiple dates, see announcement.
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster